Loading…
Glimepiride and Metformin Hydrochloride Sustained Release Tablets 2mg/500mg (Glucotaj MET SR) Glimepiride and Metformin Hydrochloride Sustained Release Tablets 2mg/500mg Glimepiride and Metformin Hydrochloride Sustained Release Tablets 2mg/500mg Glimepiride and Metformin Hydrochloride Sustained Release Tablets 2mg/500mg Glimepiride and Metformin Hydrochloride Sustained Release Tablets 2mg/500mg

GENERIC NAME OF THE MEDICINAL PRODUCT:

A. Glimepiride and Metformin Hydrochloride Sustained Release Tablets 0.5mg/500mg
B. Glimepiride and Metformin Hydrochloride Sustained Release Tablets 0.5mg/1000mg
C. Glimepiride and Metformin Hydrochloride Sustained Release Tablets 1mg/500mg
D. Glimepiride and Metformin Hydrochloride Sustained Release Tablets 1mg/850mg
E. Glimepiride and Metformin Hydrochloride Sustained Release Tablets 1mg/1000mg
F. Glimepiride and Metformin Hydrochloride Sustained Release Tablets 2mg/500mg
G. Glimepiride and Metformin Hydrochloride Sustained Release Tablets 2mg/850mg
H. Glimepiride and Metformin Hydrochloride Sustained Release Tablets 2mg/1000mg
I. Glimepiride and Metformin Hydrochloride Sustained Release Tablets 3mg/500mg
J. Glimepiride and Metformin Hydrochloride Sustained Release Tablets 3mg/850mg
K. Glimepiride and Metformin Hydrochloride Sustained Release Tablets 3mg/1000mg
L. Glimepiride and Metformin Hydrochloride Sustained Release Tablets 4mg/500mg
M. Glimepiride and Metformin Hydrochloride Sustained Release Tablets 4mg/1000mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A. Glimepiride and Metformin Hydrochloride Sustained Release Tablets 0.5mg/500mg
Each uncoated tablet contains:
Glimepiride IP……………………….0.5mg
Metformin Hydrochloride IP………….500mg
(In sustained release form)
Excipients…………………………………...q.s.

B. Glimepiride and Metformin Hydrochloride Sustained Release Tablets 0.5mg/1000mg
Each uncoated tablet contains:
Glimepiride IP……………………….0.5mg
Metformin Hydrochloride IP………….1000mg
(In sustained release form)
Excipients…………………………………...q.s.

C. Glimepiride and Metformin Hydrochloride Sustained Release Tablets 1mg/500mg
Each uncoated tablet contains:
Glimepiride IP……………………….1mg
Metformin Hydrochloride IP………….500mg
(In sustained release form)
Excipients…………………………………...q.s.

D. Glimepiride and Metformin Hydrochloride Sustained Release Tablets 1mg/850mg
Each uncoated tablet contains:
Glimepiride IP……………………….1mg
Metformin Hydrochloride IP………….850mg
(In sustained release form)
Excipients…………………………………...q.s.

E. Glimepiride and Metformin Hydrochloride Sustained Release Tablets 1mg/1000mg
Each uncoated tablet contains:
Glimepiride IP……………………….1mg
Metformin Hydrochloride IP………….1000mg
(In sustained release form)
Excipients…………………………………...q.s.

F. Glimepiride and Metformin Hydrochloride Sustained Release Tablets 2mg/500mg
Each uncoated tablet contains:
Glimepiride IP……………………….2mg
Metformin Hydrochloride IP………….500mg
(In sustained release form)
Excipients…………………………………...q.s.

G. Glimepiride and Metformin Hydrochloride Sustained Release Tablets 2mg/850mg
Each uncoated tablet contains:
Glimepiride IP……………………….2mg
Metformin Hydrochloride IP………….850mg
(In sustained release form)
Excipients…………………………………...q.s.

H. Glimepiride and Metformin Hydrochloride Sustained Release Tablets 2mg/1000mg
Each uncoated tablet contains:
Glimepiride IP……………………….2mg
Metformin Hydrochloride IP………….1000mg
(In sustained release form)
Excipients…………………………………...q.s.

I. Glimepiride and Metformin Hydrochloride Sustained Release Tablets 3mg/500mg
Each uncoated tablet contains:
Glimepiride IP……………………….3mg
Metformin Hydrochloride IP………….500mg
(In sustained release form)
Excipients…………………………………...q.s.

J. Glimepiride and Metformin Hydrochloride Sustained Release Tablets 3mg/850mg
Each uncoated tablet contains:
Glimepiride IP……………………….3mg
Metformin Hydrochloride IP………….850mg
(In sustained release form)
Excipients…………………………………...q.s.

K. Glimepiride and Metformin Hydrochloride Sustained Release Tablets 3mg/1000mg
Each uncoated tablet contains:
Glimepiride IP……………………….3mg
Metformin Hydrochloride IP………….1000mg
(In sustained release form)
Excipients…………………………………...q.s.

L. Glimepiride and Metformin Hydrochloride Sustained Release Tablets 4mg/500mg
Each uncoated tablet contains:
Glimepiride IP……………………….4mg
Metformin Hydrochloride IP………….500mg
(In sustained release form)
Excipients…………………………………...q.s.

M. Glimepiride and Metformin Hydrochloride Sustained Release Tablets 4mg/1000mg
Each uncoated tablet contains:
Glimepiride IP……………………….4mg
Metformin Hydrochloride IP………….1000mg
(In sustained release form)
Excipients…………………………………...q.s.

THERAPEUTIC INDICATIONS:

Glimepiride & Metformin is used for the treatment of type 2 diabetes mellitus, when diet, exercise and glimepiride or metformin alone is unable to control your blood sugar levels adequately.

CAUTION & SCHEDULE:

CAUTION: The tablet should not be broken crushed or chewed and swallowed whole.
Read enclosed leaflet before use.
SCHEDULE “H” Prescription Drug -Warning: Not to be sold by retail without the prescription of a Registered Medical Prescriber.
KEEP MEDICINE OUT OF REACH OF CHILDREN.

STORAGE & DOSAGE:

Storage: Protect form moisture at a temperature not exceeding 30˚C.
Do not freeze.
Keep the container tightly closed in order to protect from moisture.
Dosage: As directed by the Physician.

Glimepiride and Metformin Hydrochloride Sustained Release Tablets 2mg/500mg Technical Specification:

Product Name:
Glimepiride and Metformin Hydrochloride Sustained Release Tablets 2mg/500mg
Brand Name:Glucotaj MET SR
Strength:0.5mg/500mg, 0.5mg/1000mg,
1mg/500mg, 1mg/850mg, 1mg/1000mg,
2mg/500mg, 2mg/850mg, 2mg/1000mg,
3mg/500mg, 3mg/850mg, 3mg/1000mg,
4mg/500mg, 4mg/1000mg
Dosage Form:Tablets (un-coated)
Route of Administration:Via Oral Route
Packing:10s, 15s, 100s, 150s
Pack Insert/Leaflet:PIL (Patient Information Leaflet)
Regulatory Documents:COA, MOA, Stability Studies, GMP
Therapeutic use:Anti-diabetic, sulfonylureas
Indication: Glimepiride & Metformin is used for the treatment of type 2 diabetes mellitus, when diet, exercise and glimepiride or metformin alone is unable to control your blood sugar levels adequately.
Storage:Protect form moisture at a temperature not exceeding 30˚C.Do not freeze. Keep the container tightly closed in order to protect from moisture.

GENERIC NAME OF THE MEDICINAL PRODUCT:

  • Glimepiride and Metformin Hydrochloride Sustained Release Tablets 2mg/500mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • Glimepiride and Metformin Hydrochloride Sustained Release Tablets 2mg/500mg
    Each uncoated tablet contains:
    Glimepiride IP……………………….2mg
    Metformin Hydrochloride IP………….500mg
    (In sustained release form)
    Excipients……………………………………q.s.

THERAPEUTIC INDICATIONS:

Glimepiride & Metformin is used for the treatment of type 2 diabetes mellitus, when diet, exercise and glimepiride or metformin alone is unable to control your blood sugar levels adequately.

CAUTION & SCHEDULE:

CAUTION:  The tablet should not be broken crushed or chewed and swallowed whole.

Read enclosed leaflet before use.

SCHEDULE “H” Prescription Drug -Warning:  Not to be sold by retail without the prescription of a Registered Medical Prescriber.

Keep medicine out of reach of children.

STORAGE & DOSAGE:

Storage:  Protect form moisture at a temperature not exceeding 30˚C.  Do not freeze.  Keep the container tightly closed in order to protect from moisture.

Dosage:  As directed by the Physician.